.OncoC4 is actually taking AcroImmune-- and its in-house professional production abilities-- under i...
.Amgen has shared (PDF) the first phase 3 information on its $400 million eczema drug, connecting th...
.Biogen and also UCB's rely on improving in to phase 3 on the back of a failed research study hopes ...
.Italian biotech Aptadir Therapeutics has released along with the promise that its own pipeline of p...
.Wave Lifestyle Sciences has fulfilled its own target in a Duchenne muscular dystrophy (DMD) study, ...
.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, occupying the...
.Achilles Therapies has wrecked its tactic. The English biotech is actually quiting working on its c...
.Aligos Rehabs is actually proclaiming a midstage succeed in metabolic-dysfunction connected steatoh...
.Basilea Pharmaceutica's job building new antifungals has gotten a considerable improvement coming f...
.Having presently scooped up the U.S. rights to Capricor Therapies' late-stage Duchenne muscular dys...